Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2453)
All Articles published online
|
Oct 21, 2005 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu JH, Zhu MH, Lin J, Ni CR, Li FM, Zhu Z, Yu GZ. Effects of hepatitis B virus on p53 expression in hepatoma cell line SMMU-7721. World J Gastroenterol 2005; 11(39): 6212-6215 [PMID: 16273653 DOI: 10.3748/wjg.v11.i39.6212] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i39/6212.htm |
| Number | Citing Articles |
| 1 |
Palittiya Sintusek, Teerasak Phewplung, Anapat Sanpavat, Yong Poovorawan. Liver tumors in children with chronic liver diseases. World Journal of Gastrointestinal Oncology 2021; 13(11): 1680-1695 doi: 10.4251/wjgo.v13.i11.1680
|
| 2 |
Nur Rahadiani, Marini Stephanie, Alif Perkasa, Diah Handjari, Ening Krisnuhoni. p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma. Molecular and Clinical Oncology 2023; 19(1) doi: 10.3892/mco.2023.2650
|
| 3 |
Li-Juan Su, Guang-Wei Ding, Zhi-Li Yang, Shou-Bing Zhang, Yu-Xiu Yang, Cun-Shuan Xu. Expression patterns and action analysis of genes associated with hepatitis virus infection during rat liver regeneration. World Journal of Gastroenterology 2006; 12(47): 7626-7634 doi: 10.3748/wjg.v12.i47.7626
|
| 4 |
Jeronimo A Nogueira, Suzane K Ono-Nita, Marcelo E Nita, Marcelo MT de Souza, Eliane P do Carmo, Evandro S Mello, Cristovan Scapulatempo, Denise C Paranaguá-Vezozzo, Flair J Carrilho, Venancio AF Alves. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-204
|
| 5 |
Salyavit Chittmittrapap, Thaweesak Chieochansin, Roongruedee Chaiteerakij, Sombat Treeprasertsuk, Naruemon Klaikaew, Pisit Tangkijvanich, Piyawat Komolmit, Yong Poovorawan. Prevalence of Aflatoxin Induced p53 Mutation at Codon 249 (R249s) in Hepatocellular Carcinoma Patients with and without Hepatitis B Surface Antigen (HBsAg). Asian Pacific Journal of Cancer Prevention 2013; 14(12): 7675 doi: 10.7314/APJCP.2013.14.12.7675
|
| 6 |
Pierre Manda, Aholia Jean-Baptiste Adépo, Alphonsine Kouassi M’bengue, Michel Konan, Jean Verdier N’gbe, Moussa Doumbia, Toussaint Toutou, Sébastien Djédjé Dano. Évaluation du rôle de l’aflatoxine B1 dans l’apparition du carcinome hépatocellulaire en Côte d’Ivoire : étude préliminaire. Toxicologie Analytique et Clinique 2018; 30(2): 85 doi: 10.1016/j.toxac.2018.02.001
|
| 7 |
Jianhui Qu, Jing Lin, Shuhui Zhang, Zhi Zhu, Canrong Ni, Shunmin Zhang, Hengjun Gao, Minghua Zhu. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells. Biochemical and Biophysical Research Communications 2009; 386(3): 504 doi: 10.1016/j.bbrc.2009.06.081
|
| 8 |
Guangyan Liu, Xiancai Ma, Zhe Wang, Kousho Wakae, Yaochang Yuan, Zhangping He, Hironori Yoshiyama, Hisashi Iizasa, Hui Zhang, Mami Matsuda, Ryuichi Sugiyama, Zhiyu Yuan, Masamichi Muramatsu, Linghua Li. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing. Journal of Biological Chemistry 2019; 294(38): 14043 doi: 10.1074/jbc.RA119.007970
|